Clinical Trials
Dr Hope S. Rugo Discusses Clinical Trial Minority Recruitment, PALOMA-2 Findings
[ad_1]
Hope S. Rugo, MD, FASCO, is professor of medicine and the director of the Breast Oncology and Clinical Trials Education program at the Uni...
Dr. Kekoa Taparra highlights importance of data disaggregation in Pacific Islander health - State of Reform
[ad_1]
Accurate representation of Native Hawaiians and Pacific Islanders (NHPI) is sorely needed in the health care system, especially as the lon...
Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fract...
[ad_1]
Nonstandard Abbreviations and Acronyms
ARNI
angiotensin receptor neprilysin inhibitor
HFrEF
heart failure with reduced ejection fra...
#VisualAbstract: Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial
[ad_1]
1. A double-blinded, randomized controlled trial found that varenicline significantly improved the rate of abstinence from smoking in Afr...
Epidemiology of indigenous Plasmodium knowlesi infection in Sarawak, 2011‐2019
[ad_1]
Abstract
Objectives
To characterize the state-wide epidemiology of indigenous knowlesi malaria in Sarawak from 2011-2019.
Methods
Longitudin...
Factors associated with enrolment in clinical trials among women with early-stage breast cancer
[ad_1]
Background:
Clinical trials allow development of innovative treatments and ameliorate the quality of cli...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
